Want to see VMD full AI Analyst Report?
VMD Stock Chart & Stats
$9.26
-$0.02(-0.22%)
At close: 4:00 PM EDT
$9.26
-$0.02(-0.22%)
Day’s Range― - ―
52-Week Range$6.05 - $12.61
Previous Close$9.28
Volume155.15K
Average Volume (3M)333.65K
Market Cap
$326.42M
Enterprise Value$471.69
Total Cash (Recent Filing)$10.68M
Total Debt (Recent Filing)$11.60M
Price to Earnings (P/E)23.5
Beta0.52
Next Earnings
Nov 03, 2026EPS Estimate
0.13Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.38
Shares Outstanding38,088,226
10 Day Avg. Volume302,673
30 Day Avg. Volume333,654
Financial Highlights & Ratios
PEG Ratio0.63
Price to Book (P/B)2.04
Price to Sales (P/S)1.07
P/FCF Ratio24.22
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda<0.01
Forecast
1Y Price Target
$11.00Price Target Upside18.79% Upside
Rating ConsensusHold
Number of Analyst Covering1
EPS Forecast (FY)0.46
Revenue Forecast (FY)$317.30M
Bulls Say, Bears Say
Bulls Say
Strong Revenue And Patient GrowthSustained growth in revenue and active patients expands Viemed’s recurring therapy base. Rising ventilator, sleep-therapy and resupply volumes can deepen referral relationships and support durable operating scale.
Strong Cash Generation And Net CashPositive operating cash flow, improving free cash flow and a net-cash position strengthen financial flexibility. Viemed can fund growth, technology investment and capital returns without relying heavily on additional borrowing.
Improving Operational ScalabilityFaster intake and qualification processing can increase patient throughput without proportional infrastructure expansion. This technology-led efficiency may improve scalability and help Viemed handle growing referral and resupply demand.
Bears Say
Margin CompressionLower EBITDA margins indicate that growth is currently converting into less operating profit. If compensation, implementation and other operating costs remain elevated, margin recovery could lag revenue expansion.
Shift Toward Lower-Margin RevenueA smaller rental mix reduces the contribution from recurring, higher-margin revenue and increases exposure to lower-margin products and services. This mix shift may constrain profitability even while reported revenue grows.
Respiratory Therapist Capacity RiskTherapist availability and compliance requirements could raise labor costs or limit patient onboarding capacity. If productivity per therapist declines, Viemed may need additional hiring to sustain service quality and reimbursement eligibility.
Viemed Healthcare News
VMD FAQ
What was Viemed Healthcare Inc’s price range in the past 12 months?
Viemed Healthcare Inc lowest stock price was $6.05 and its highest was $12.61 in the past 12 months.
What is Viemed Healthcare Inc’s market cap?
Viemed Healthcare Inc’s market cap is $326.42M.
When is Viemed Healthcare Inc’s upcoming earnings report date?
Viemed Healthcare Inc’s upcoming earnings report date is Nov 03, 2026 which is in 73 days.
How were Viemed Healthcare Inc’s earnings last quarter?
Viemed Healthcare Inc released its earnings results on Aug 03, 2026. The company reported $0.07 earnings per share for the quarter, missing the consensus estimate of $0.12 by -$0.05.
Is Viemed Healthcare Inc overvalued?
According to Wall Street analysts Viemed Healthcare Inc’s price is currently Undervalued.
Does Viemed Healthcare Inc pay dividends?
Viemed Healthcare Inc does not currently pay dividends.
What is Viemed Healthcare Inc’s EPS estimate?
Viemed Healthcare Inc’s EPS estimate is 0.13.
How many shares outstanding does Viemed Healthcare Inc have?
Viemed Healthcare Inc has 38,088,226 shares outstanding.
What happened to Viemed Healthcare Inc’s price movement after its last earnings report?
Viemed Healthcare Inc reported an EPS of $0.07 in its last earnings report, missing expectations of $0.12. Following the earnings report the stock price went down -15.868%.
Which hedge fund is a major shareholder of Viemed Healthcare Inc?
Currently, no hedge funds are holding shares in VMD
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Viemed Healthcare Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$11.00 (18.79% Upside)
$11.00 (18.79% Upside)
Blogger Sentiment
Neutral
VMD Sentiment 67%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Decreased
By 4.5K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $347.2K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.9%
Last 30 Days ▼ 10.4%
Last 30 Days ▼ 10.4%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
98.03%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
10.63%
Trailing 12-Months
Company Description
Viemed Healthcare Inc
Viemed Healthcare, Inc., through its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services in the United States. The company provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD. It also sells and rents HME devices, such as non-invasive and invasive ventilators, positive airway pressure (PAP) machines, durable medical equipment, percussion vests, oxygen concentrators, and other medical equipment. In addition, the company provides neuromuscular care and oxygen therapy services; and sleep apnea management which provides sleep solutions and/or equipment, such as PAP, automatic continuous positive airway pressure, and bi-level positive airway pressure machines. Further, it offers in-home sleep apnea testing services; and breast pumps and related lactation equipment and supplies, including fulfillment and support services, as well as healthcare staffing and recruitment services. Viemed Healthcare, Inc. was founded in 2006 and is headquartered in Lafayette, Louisiana.
VMD Company Deck
VMD Earnings Call
Q2 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call presented multiple material operational and financial positives: record revenue, the largest-ever active ventilator patient base, strong sequential and year-over-year growth in sleep and resupply, improving compliance, improved cash generation, and clear investments in technology and scalability (e.g., Tenor). Offsetting these were margin pressures in adjusted EBITDA and gross margin driven by revenue mix shifts, temporary maternal health transition costs, higher SG&A from deliberate scaling and one-time duplicative costs, and some near-term uncertainty on RT capacity. Management communicated confidence in the growth trajectory, provided constructive explanations for margin dynamics, and raised revenue guidance while outlining levers for second-half operating leverage.View all VMD earnings summariesVMD Stock 12 Month Forecast
All Analysts
Top Analysts
Average Price Target
$11.00
▲(18.79% Upside)
Technical Analysis
1 Day
3 Days
1 Week
1 Month
Ownership Overview
13.93% Insiders
13.16% Mutual Funds
21.19% Other Institutional Investors
42.99% Public Companies and
Individual Investors










